EFFICACY OF 17-α-HYDROXY-PROGESTRONE IN PREVENTION OF PRETERM LABOR IN HIGH RISK PREGNANT WOMEN

Authors

  • Wajiha Shadab
  • Shazia Riaz
  • Farzana Aftab
  • Faizan Hassan Shah Ayub Medical College

Abstract

Background: Preterm delivery (before 37 completed weeks of gestation) is a major determinant of infant mortality. The objective of study was to determine the efficacy of 17-alpha hydroxy-progesterone in preventing delivery before 37 weeks of gestation in high risk women. Methods: This study, a randomized controlled trial was conducted in Obstetrics OPD, observing all scientific and ethical protocols. The women with less than 20 weeks gestation and with a past history of preterm delivery were included. A total of 132 women fulfilled the study requirements. Two groups made were as follows: Group A (Treatment group received intramuscular 17-alpha hydroxy-progesterone) and Group B served as control (The control group revived intramuscular Neurobion). A total of 66 women were assigned to each group. The data was recorded on a specially designed proforma for statistical analysis and comparison following the standard procedure. Results: The criterion was strictly observed. The results showed a statistically significant (p<0.01) difference between group A as compared to group B. Conclusion: 17-α-Hydroxyprogesterone was found to be an effective drug in preventing delivery before 37 weeks in women at risk.Keywords: 17-Alpha-hydroxyprogesterone; Preterm labour; High risk pregnancy

Author Biography

Faizan Hassan Shah, Ayub Medical College

PGT FCPS 1 Trainee, Surgical C unit. Ayub Teaching Hospital

References

Butler AS, Behrman RE, editors. Preterm birth: causes, consequences, and prevention. Washington (DC): National Academies Press; 2007.

Rush RW, Davey DA, Segall ML. The effect of preterm delivery on perinatal mortality. Br J Obstet Gynaecol 1978;85(11):806–11.

Nelson DB, McIntire DD, McDonald J, Gard J, Turrichi P, Leveno KJ. 17-alpha Hydroxyprogesterone caproate did not reduce the rate of recurrent preterm birth in a prospective cohort study. Am J Obstet Gynecol 2017;216(6):e600–1.

O’Brien JM, Adair CD, Lewis DF, Hall DR, Defranco EA, Fusey S, et al. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2007;30(5):687–96.

Bittar ER, Yamasaki AA, Sasaki S, Zugaib M. Cervical fetal fibronectina in patients at increased risk for preterm delivery. Am J Obstet Gynecol 1996;175(1):178–81.

Cunningham FG, Gant NF, Leveno KJ, Gilstrap III LC, Hauth JC, Wenstrom KD. Preterm and postterm pregnancy and fetal growth retardation. In: Williams’ obstetrics. 20th ed. New Jersey: Prentice-Hall International, 1997; p.797–826.

Erny R, Pigne A, Prouvost C, Gamerre M, Malet C, Serment H, et al. The effects of oral administration of progesterone for premature labor. Am J Obstet Gynecol 1986;154(3):525–9.

Check JH, Lee G, Epstein R, Vetter B. Increased rate of preterm deliveries in untreated women with luteal phase deficiencies. Gynecol Obstet Invest 1992;33(3):183–4.

Lockwood CJ, Senyei AE, Dischie MR, Casal D, Shah KD, Thug SN, et al. Fetal fibronectina in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med 1991;325(10):669–74.

Michal A, Elovitz, MD, Conjecvarm M. The use of progestational agents for preterm birth: lessons from a mouse model. Am J Obstet Gynecol 2006;195(4):1004–10.

Society for Maternal-Fetal Medicine (SMFM) Publications Committee. The choice of progestogen for the prevention of preterm birth in women with singleton pregnancy and prior preterm birth. Am J Obstet Gynecol 2017;216(3):B11–3.

Romero R, Yeo L, Miranda J, Hassan SS, Conde-Agudelo A, Chaiworapongsa T. A blueprint for the prevention of preterm birth: vaginal progesterone in women with a short cervix. J Perinat Med 2013;41(1):27–44.

Paneth NS. The problem of low birth weight. Future Child 1995;5(1):19–34.

Mattison DR, Damus K, Fiore E, Petrini J, Alter C. Preterm delivery: a public health perspective. Paediatr Perinat Epidemiol 2001;15(2):7–16.

Creasy RK. Preterm birth prevention: where are we? Am J Obstet Gynecol 1993;168(4):1223–30.

Johnson JW, Austin KL, Jones GS, Davis GH, King TM. Efficacy of 17alpha-hydroxyprogesterone caproate in the prevention of premature labor. N Engl J Med 1975;293(14):675–80.

Hauth JC, Gilstrap LC 3rd, Brekken AL, Hauth JM. The effect of 17 alpha-hydroxyprogesterone caproate on pregnancy outcome in an active-duty military population. Am J Obstet Gynecol 1983;146(2):187–90.

Hobel CJ, Ross MG, Bemis RL, Bragonier JR, Nessim S, Sandhu M, et al. The West Los Angeles Preterm Birth Prevention Project. I. Program impact on high-risk women. Am J Obstet Gynecol 1994;170(1 Pt 1):54–62.

Fuchs F, Stakemann G. Treatment of threatened premature labor with large doses of progesterone. Am J Obstet Gynecol 1960;79:172–6.

Fuchs AR, Fuchs F. Endocrinology of human parturition: a review. Br J Obstet Gynaecol 1984;91(10):948–67.

American college of obstetricians and gynaecologists. ACOG committee opinion: use of progesterone to reduce preterm birth. Obstet Gynecol 2003;102(5 Pt 1):1115–6.

Rittenberg C, Newman RB, Istwan NB, Rhea DJ, Stanziano GJ. Preterm birth prevention by 17 alpha-hydroxyprogesteronecaproate vs. Daily Nursing Surveillance. J Reprod Med 2009;54(2):47–52.

Published

2018-03-16

Issue

Vol. 30 No. 2 (2018): JOURNAL OF AYUB MEDICAL COLLEGE, ABBOTTABAD

Section

ORIGINAL ARTICLE

License

Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License  CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.

USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.

AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.